Doxazosin Tablet
FDA Label NDC 70771-1113

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Doxazosin (NDC 70771-1113). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1112-1 in bottle of 100 Tablets

Doxazosin Tablets USP, 1 mg

Rx only

100 Tablets

Container Label 1 mg (100s count)

NDC 70771-1113-1 in bottle of 100 Tablets

Doxazosin Tablets USP, 2 mg

Rx only

100 Tablets

Container Label 2 mg- 100s Count (Ffdedf13 4b6d 489c 87e0 2e24385a6295 05)

NDC 70771-1114-1 in bottle of 100 Tablets

Doxazosin Tablets USP, 4 mg

Rx only

100 Tablets

Container Label 4 mg (100s count)

NDC 70771-1115-1 in bottle of 100 Tablets

Doxazosin Tablets USP, 8 mg

Rx only

100 Tablets

Container Label (8 mg)

* Please review the disclaimer below.